Connect 1906 Phase 2 trial of a novel peptide vaccine (PEP-CMV) targeting CMV antigen for newly diagnosed pediatric high-grade glioma and diffuse intrinsic pontine glioma and recurrent medulloblastoma
Clinical Trial Grant
Awarded By
Research Institute at Nationwide Children's Hospital
Start Date
June 12, 2024
End Date
December 31, 2026
Awarded By
Research Institute at Nationwide Children's Hospital
Start Date
June 12, 2024
End Date
December 31, 2026